Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase
- 1 November 2009
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 16 (5) , 413-424
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- A Feedback Loop Involving the Phd3 Prolyl Hydroxylase Tunes the Mammalian Hypoxic Response In VivoMolecular and Cellular Biology, 2009
- Highly parallel identification of essential genes in cancer cellsProceedings of the National Academy of Sciences, 2008
- Prolyl Hydroxylase PHD3 Activates Oxygen-dependent Protein AggregationMolecular Biology of the Cell, 2008
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008
- Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failureBlood, 2008
- Regulation of adult erythropoiesis by prolyl hydroxylase domain proteinsBlood, 2008
- The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressorGenes & Development, 2008
- HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaquesBlood, 2007
- Placental but Not Heart Defects Are Associated with Elevated Hypoxia-Inducible Factor α Levels in Mice Lacking Prolyl Hydroxylase Domain Protein 2Molecular and Cellular Biology, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005